Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS

Area of Science:

• Neuroimmunology
• Molecular Medicine
• Clinical Neurology

Background:

• Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
• Clinically isolated syndrome (CIS) represents the first neurological episode suggestive of MS.
• Understanding the molecular mechanisms underlying the transition from CIS to MS is crucial for early intervention.

Purpose of the Study:

• To investigate the expression of key adhesion molecules and matrix metalloproteinases in patients with CIS and their evolution to clinically definite MS (CDMS).
• To identify potential biomarkers associated with disease progression in early MS.

Main Methods:

• Flow cytometry was used to assess the surface expression of LFA-1alpha, VLA-4, and ICAM-1 on peripheral blood mononuclear cells (PBMC) and cerebrospinal fluid (CSF) cells.
• Enzyme-linked immunosorbent assay (ELISA) was employed to measure serum and CSF concentrations of soluble VCAM-1, ICAM-1, E-Selectin, MMP-9, and MMP-2.
• Patients with CIS and CDMS were compared with healthy control subjects.

Main Results:

• Significantly increased surface expression of LFA-1alpha and VLA-4 was observed on T cells and monocytes in both peripheral blood and CSF of CIS and CDMS patients compared to controls.
• LFA-1alpha and VLA-4 expression levels were notably higher in patients who progressed to CDMS than in those with CIS.
• Elevated serum levels of MMP-9 and increased CSF concentrations of sVCAM-1 and s-E-Selectin were found in patients with CIS and CDMS compared to controls.

Conclusions:

• VLA-4, LFA-1alpha, and MMP-9 are implicated in the inflammatory demyelination process during the transition from CIS to CDMS.
• These molecules represent potential therapeutic targets for preventing or slowing the progression of MS.
• Monitoring these markers could aid in predicting disease course in patients with CIS.